Please enable JS


Investor Overview

Corporate Profile

Zai Lab (NASDAQ: ZLAB) is a Shanghai-based innovative biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. The company’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast growing segments of China’s pharmaceutical market and global unmet medical needs. Zai Lab’s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partner’s and its own products in order to impact human health worldwide.

Stock Quote


Data as of

Copyright West LLC. Minimum 15 minutes delayed.

Upcoming Events
More events are coming soon.

Email Alerts

Sign up to receive email alerts whenever Zai Lab Limited financial posts new information to the site.

Click Here